These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15127006)

  • 1. Progressive beta cell failure in type 2 diabetes mellitus of youth.
    Gungor N; Arslanian S
    J Pediatr; 2004 May; 144(5):656-9. PubMed ID: 15127006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes.
    Stumvoll M; Gerich J
    Clin Lab Med; 2001 Mar; 21(1):31-51. PubMed ID: 11321936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates.
    Saad R; Gungor N; Arslanian S
    Pediatr Diabetes; 2005 Jun; 6(2):95-9. PubMed ID: 15963037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-cell expansion for therapeutic compensation of insulin resistance in type 2 diabetes.
    Efrat S
    Int J Exp Diabesity Res; 2003; 4(1):1-5. PubMed ID: 12745664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
    Chiu HK; Tsai EC; Juneja R; Stoever J; Brooks-Worrell B; Goel A; Palmer JP
    Diabetes Res Clin Pract; 2007 Aug; 77(2):237-44. PubMed ID: 17234296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell deficiency, insulin resistance, or both?
    Cahill GF
    N Engl J Med; 1988 May; 318(19):1268-70. PubMed ID: 3283556
    [No Abstract]   [Full Text] [Related]  

  • 9. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.
    Polonsky KS; Sturis J; Bell GI
    N Engl J Med; 1996 Mar; 334(12):777-83. PubMed ID: 8592553
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-insulin dependent diabetes: beta-cell failure or insulin resistance, an unsolved controversy].
    Herrera Pombo JL
    Rev Clin Esp; 1991 Apr; 188(7):329-31. PubMed ID: 1784759
    [No Abstract]   [Full Text] [Related]  

  • 12. A signal for beta-cell failure.
    Avruch J
    Nature; 1998 Feb; 391(6670):846-7. PubMed ID: 9495335
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm.
    Green J; Feinglos M
    Int J Clin Pract Suppl; 2007 Aug; (154):3-11. PubMed ID: 17593272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlocking the secrets of the pancreatic beta cell: man and mouse provide the key.
    Hattersley AT
    J Clin Invest; 2004 Aug; 114(3):314-6. PubMed ID: 15286795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensification of therapy and no increase in body mass index with longer disease duration in type 2 diabetes mellitus (ZODIAC-5).
    Logtenberg SJ; Kleefstra N; Ubink-Veltmaat LJ; Houweling ST; Bilo HJ
    Fam Pract; 2007 Dec; 24(6):529-31. PubMed ID: 18039725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin sensitivity, glucose sensitivity, and acute insulin response to glucose load in adolescent type 2 diabetes in Taiwanese.
    Pei D; Hsiao CF; Hung YJ; Hsieh CH; Fang SC; Lian WC; Hsu WL; Fu CC; Chen HD; Kuo SW
    Diabetes Metab Res Rev; 2006; 22(1):26-33. PubMed ID: 15880384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.
    Matveyenko AV; Butler PC
    Diabetes; 2006 Jul; 55(7):2106-14. PubMed ID: 16804082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Oglesby A; Hayes C; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S59-66. PubMed ID: 15324517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.